Introduction
were age stratified, and 30 samples were used for each pediatric age group, except for the 6 groups 6 months-1 year and 6 -9 years for which 29 samples were available. For the 7 adult age groups, 7 samples were available for age group 20-34 years; 15 samples for 35-8 IgG antibody (Invitrogen) diluted 1:10,000 in 50uL blocking buffer for 2 hours at room 22 temperature. Plates were then washed 4x with PBST and incubated with 50uL Ultra-23 TMB (Sigma; St. Louis, MO) for 30 minutes at room temperature. Equal volume of 2M 1 H2SO4 was added to stop the reaction and end-point OD450nm were read immediately 2 on a SpectraMax M2 plate reader. Statistical tests were done using a two-sample T-test. 3
Western confirmation was performed for two matched serum samples from India by 4 running 5ug of purified klassevirus 3C protease on 4-12% Bis-Tris NuPage gels, 5 transferring using the XCell II Blot Module, and staining overnight at 4 C using 5uL of 6 human serum diluted 1:200 into 1 mL of 5% milk in PBST, and developing with Western 7
Lightning enhanced luminal reagent. Western blots were scanned on an Epson Perfection 8 V350 Photo scanner and quantitated using Licor Odyssey 2.1 software. 9
Results

11
Purification of klassevirus 3C protease 12
Klassevirus 3C protease was expressed as an N-terminal 6xHis-tagged fusion proteins 13 and purified using NiNTA affinity chromatography and followed by gel filtration FPLC. 14 SDS-PAGE analysis with Coommassie stain and silver stain was used to confirm the 15 purity of products at each stage ( Figure 1 ). The inclusion of reducing agents (at least 16 5mM BME) was the most important factor in increasing the solubility of the product 17 had an average OD450 that was greater than the highest OD450 for a pre-infection Indian 2 serum sample. Using a specific OD450 cut-off of 0.300 (a value that separates pre-3 infection and post-infection OD450 in the seroconverting Indian samples) yielded 16 4 (5.3%) seropositives in the pediatric St. Louis cohort and eight (14.5%) seropositives in 5 the adult cohort. There was no significant association between klassevirus seropositivity 6 and sex in either the pediatric or adult cohort. 7 8
Discussion
9
The data in this study indicate that IgG antibodies are generated against the 3C 10 protease after klassevirus infection. This represents the first demonstration of a human 11 antibody response to a klassevirus antigen and suggests that bona fide human infection by 12 klassevirus occurs. Based on the available convalescent serum samples, IgG antibodies 13 could be detected in some instances as long as 7 months after infection. It is unclear how 14 long the antibody response to klassevirus 3C persists and more extensive studies, using 15 longitudinal serum samples are needed to address this issue. 16
Screening of an age-banded cohort of 353 serum samples from St. Louis 17
Children's Hospital yielded only a handful of positive samples using a cut-off value 18 defined by the average of the pre-infection samples from India. This observation 19 suggests either that klassevirus infection rate in the United States is quite low or that anti-20 klassevirus 3C antibodies may not be long lived. To assess this further, a larger sample 21 size and/or serial samples taken from individuals with klassevirus confirmed stool 22 samples would be required. 23
To date, klassevirus has only been detected via PCR of stool and sewage samples 1 (3, 4, 7) . Importantly, 3C protease is not present in picornaviral virions and studies of 2 hepatitis A experimental infections in chimpanzee indicate that anti-3C antibodies are 3 only generated in actively infected individual (5). Thus, our data are consistent with the 4 notion that klassevirus replicates in humans and is not merely a virus of some human 5 foodstuff. 6
No culture system for klassevirus has been described to date. Thus, recombinant 7 viral proteins are the only currently viable capture reagents for determining 8 seroprevalence. Attempts to use capsid VP1 protein for serological analysis, as has been 9 used for other picornaviruses, were hindered by an inability to refold the purified 10 denatured protein. Our experience with purification of VP1 is not atypical. Previous 11 attempts have required purification from inclusion bodies and subsequent refolding on 12 gel filtration columns (2, 10). Use of previous published protocols for the purification of 13 VP1 were not successful, although this does not preclude future optimization to recover 14 correctly-folded protein (2, 10). Non-structural proteins, such as 3C, have also been used 15 to determine seroprevalence of picornaviruses (5). From a technical perspective, non-16 structural proteins are more likely to be soluble than structural proteins and are easier to 17 assay for activity and correct folding. Furthermore, detection of an immune response 18 mediated against non-structural proteins that are not present in the virion is suggestive of 19 viral replication in vivo. Previous studies on HAV infection also suggested the severity 20 of infection is correlated with the development of anti-3C antibodies (5, 9). However, 21 these studies also suggest that there is heterogeneity in the development of anti-3C and 22
anti-structural protein antibodies. Not every infected individual will develop anti-3C 23 antibodies, even though anti-structural protein antibodies and evidence of clinical 1 infection may develop. In this study, we note that two of six klassevirus-infected 2 individuals showed no increase in anti-3C antibody levels. 3
Unambiguously ascertaining the seroprevalence of new agents such as klassevirus 4 in a population is complicated by the lack of true positive and negative controls. For 5 example, the infection history of the "pre-infection" Indian serum samples and the 0-6 6 month olds in the St. Louis cohort is not known. In this study, we made the assumption 7 that the "pre-infection" Indian serum samples represent seronegative individuals to create 8 a specific cut-off value for seropositivity. Using these criteria, a seroprevalence of 6.8% 9 was found in 353 serum samples from St. Louis. This seroprevalence is fairly low for a 10 virus that has, to date, only been found in young children. This may be indicative of 11 highly sporadic infection in St. Louis of klassevirus or may be suggestive of a short-lived 12 antibody response to the 3C protease, as indicated by an inconsistent increase in 13 seroprevalence with increasing age (Figure 3) . An alternative way to analyze the 14 seroprevalence would be to assume that the 0-6 month samples are negative based on 15 their low OD450 values and extremely young age and to create a common ELISA 16 seropositivity cut-off of 2-or 3-standard deviations above the mean 0-6 month OD450. 17
The number of seropositive samples using this method would be 121 (34.3%) or 85 18 (24%) samples, respectively. However, using the 2-standard deviation seropositive cut-19 off would count 5 of the 6 pre-infection matched India serum samples as seropositive. 20
This may be a reasonable conclusion given the higher detection of klassevirus by RT-21 PCR in stool from Indian children than has been reported in the US (3, 4, 7). However, 22 maternal antibodies would be unlikely to account for any seropositivity in the pre-23 infection samples, as 4 of the 6 children were more than a year of age at the date of serum 1
collection. 2
In this study, a small number of longitudinal serum samples (up to a year 3 following the acute positive stool sample) from klassevirus-infected individuals were 4 tested, demonstrating that high titers persist for at least 6 months. Ideally, a much longer 5 longitudinal cohort should be examined to define the lifetime of an anti-klassevirus 3C 6 response in a given individual. Studies on anti-3C antibodies from HAV suggest that 7
anti-3C antibodies remain detectable in serum for up to 15 months after infection (5). 8
The possibility of short-lived anti-3C antibody may explain why we fail to observe a 9 clear upward trend in seropositivity across different age bands, though sample sizes for 10 each age band were small and the adult population seemed to have a higher 11 seroprevalence than the pediatric population. We also failed to observe seropositivity in 12 children <6 months old, indicating a lack of maternally transmitted anti-3C antibodies in 13 this population. 14 Future studies will be required to ascertain seroprevalence across different 15 populations, environments, and age-bands. Neutralization tests or virus-like particle-16 based ELISAs could provide an orthogonal test for klassevirus serology. We would also 17 like to know how often klassevirus can infect an individual and whether neutralizing 18 antibodies are generated. Of special interest is the use of klassevirus serology to 19 determine potential associations with clinical disease in humans aside from diarrhea. 
